Clinical Trial Update: Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial update evaluating peripheral blood stem cell mobilization in relapsed lymphoma patients treated with bendamustine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Bendamustine (Treanda) (bendamustine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Lymphoma | EARLY_Phase 1 | Status: COMPLETED